Best Gallbladder cancer oncologists: TOP 154 doctors

Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.

Member of SICOB - Italian Society of Obesity Surgery and ACOI - Association of Italian Hospital Surgeons                                               

Dr Braun is a board-certified general surgeon with over 25 years of experience specializing in gastrointestinal surgery, particularly in the treatment of gastroesophageal reflux disease (GERD) through Fundoplication surgery. He has performed over 500 successful Nissen and Toupet Fundoplication procedures, with a focus on minimally invasive laparoscopic techniques. His expertise extends to diagnosing complex cases of GERD and offering comprehensive treatment plans to improve patient outcomes.

He has carried out his main training experiences in various international institutions and specialization courses in general and digestive system surgery, including a two-year training internship at Johns Hopkins University, Division of Hepatobiliary Pancreatic Surgery and numerous courses in Madrid, with Prof. E. Moreno Gonzales (Curso Internacional de Actualizaciòn en chirurgia General y del Aparato Digestivo) or in New Orleans (Medical Education at the 90th Annual Clinical Congress of the American College of Surgeons).

Dr. Braun has extensive expertise in the field of digestive surgery. He has focused on implementing advanced protocols and optimizing surgical techniques, while maintaining high standards of safety and patient care. He has collaborated with a multidisciplinary team to provide an integrated and personalized approach in the management of obese or digestive disorder patients, improving quality of life and reducing post-operative complications.

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.

Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.

In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.

Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.

Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).

Areas of Interest

• Breast Cancer
• Prostate Cancer
• Gastrointestinal System Tumors
• Gynecological Tumors
• Brain Tumors
• Lung Cancer

Education
2021:

• Professor Title, Health Sciences University Hamidiye Faculty of Medicine

2017 – 2018:

• Master's Degree in Phytotherapy, Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University

2015:

• Associate Professor Title

1996:

• Radiation Oncology Specialization, Princess Margaret Hospital, Toronto, Canada

1994 – 1998:

• Radiation Oncology Specialization, Şişli Etfal Training and Research Hospital

1982 – 1988:

• Trakya University Faculty of Medicine

Work Experience
2024:

• Neolife Medical Center – Biruni University

2021 – 2024:

• Health Sciences University (Hamidiye Faculty of Medicine – Bursa Medical Faculty – Izmir Medical Faculty – Lecturer)

2020 – 2024:

• SBÜ Başakşehir Çam and Sakura City Hospital – Education and Administrative Officer

2015 – 2020:

• Dr. Sadi Konuk Training and Research Hospital – Radiation Oncology Clinical Department Setup and Administrative Officer

2013 – 2020:

• Gelişim University – Lecturer, Radiation Therapy Technician Program

2009 – 2015:

• Istanbul Training and Research Hospital, Radiation Oncology Center Setup, Clinical Administrative Responsibility, and Chief Assistant

1998 – 2009:

• Şişli Etfal Training and Research Hospital, Radiation Oncology Clinic Chief Assistant

Professional Trainings
2023:

• Project Creation and Development on Artificial Intelligence and Radiotherapy Treatment Planning Systems with Yıldız Technical University

2023:

• Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2015:

• Turkish Radiation Oncology Association (Mammography Working Group, Integrative Working Group, Stereotactic Working Group, Uro-Oncology Working Group), Researcher

2020:

• Hydrogel Space Oar Application and Certification Training, Başakşehir Çam and Sakura City Hospital

2018:

• Distance Good Clinical Practices Training; Basic Good Clinical Practices Course

2011:

• Lifelong Learning Program Leonardo da Vinci Mobility Projects, European Union Education and Youth Programs Directorate

2008:

• Brachytherapy Training, Istanbul University, Oncology Institute

Memberships
2022 – 2024:

• President of Sakura Science and Academician Association (SABADER)

2023:

• Turkish Radiation Oncology Association, Integrative Working Group Executive Board Member

2021:

• Cam & Sakura Medical Journal, Section Editor

2018:

• Interdisciplinary Oncology Association, Substitute Member of the Executive Board

1995:

• Turkish Radiation Oncology Association

1989:

• Turkish Medical Association

Scientific Works

• A.1 Karacetin D, Yalcin B, Okten B, Oztürk S, Maral O, Incekara O (2009). Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer. JBUON, 605-608
• A.2 Yılmaz O B, Karacetin D, Kabukcuoglu F, Taskin T, Yener S (2011). Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas. Pol J Pathol, 62(1), 19-24
• A.3 Karacetin D, Cakir A, Agaoglu F, Çamlıca H, Ergen A, Dizdar Y, Darendeliler E (2010). Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of femur doses for four treatment techniques. Journal of Radiotherapy in Practice, 41-51
• A.4 Baycan D, Karacetin D, Balkanay A, Barut Y (2012). Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison. Jpn J Radiol, DOI: 10.1007/s

Education:

• 2008 – 2012: Marmara University School of Medicine (Specialization Training)
• 1998 – 2005: Istanbul University Cerrahpaşa School of Medicine

Work Experience:

• 2012 – Present: Neolife Medical Center

Memberships:

• Turkish Society of Radiation Oncology

Scientific Works:

2014:

• 11th National Radiation Oncology Congress
  • Oral Presentation: "Late-stage kidney damage after chemoradiotherapy in gastric cancer patients, clinical, functional, and dosimetric examination of tolerance doses."
  • Poster Presentation: "Early-stage stereotactic radiotherapy results in lung metastases."

2011:

• 1st Evidence-Based Medicine Course
  • "Evaluation of late side effects in patients treated with conformal radiotherapy for localized prostate cancer: A TOG Side Effects Subgroup Study."

Prof. Dr. med. Ulrich Graven

Head of the Clinic of Hematology, Oncology and Gastroenterology

Head of a certified oncology center

Head of Clinical Research Department

Specialization:

Hematology, including stem cell transplantation

Abdominal oncology, especially colorectal and pancreatic cancer therapy

Metastasis therapy, including the use of off-label drugs

Membership in professional societies:

Professional Union of German Therapists

German Society for Internal Medicine

German Cancer Society

Abdominal Oncology Working Group

German Society of Hematology and Oncology

German Working Group on Bone Marrow and Hematopoietic Cell Transplantation

German Society for Digestive and Metabolic Diseases

European Society for Medical Oncology

American Society of Clinical Oncology

American Association for Cancer Research

Activities in professional communities:

German Cancer Society:

Since 2013, speaker of the commission for certification of oncology centers

Since November 2007, member of the board

Since September 2022, Speaker of the Section of National Societies on Cancer Control

Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.

Chairman of the Oncology Society of North Rhine-Westphalia.

Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.

Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.

Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.

Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.

Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.

Member of the committee for the development of clinical guidelines for colorectal cancer.

Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.

Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.

Oncologist-mammologist

Treatment of mastopathy, which causes pain and swelling of the mammary gland

Treatment of large breast cysts without surgical aspiration

Treatment of duct ectasia (dilation) and galactorrhea

Obtaining a smear from the secretion of the mammary gland

Treatment of adenosis and other precancerous diseases of the mammary gland

Biopsy of pathological formations on the skin of the mammary gland

Hormonal treatment for breast cancer

Treatment of precancerous diseases of other organs

Cancer Treatment

Symptomatic treatment of cancer patients

Mistletoe therapy and cancer treatment with high doses of vitamin C.

Elimination of complications and side effects of chemotherapy and radiation therapy

Pain Treatment for Cancer Patients (Natural Pain Relief and Life Extension)

Participant of many conferences and seminars with the participation of German doctors in Azerbaijan, as well as in Germany and Turkey.

Dr. X has a Bachelor of Medicine from Mysore University, India and a Doctor of Medicine in radiotherapy from Banaras Hindu University, India. He is a Diplomate of the National Board of Examination and is a member of the Association of Radiation Oncology of India, Society for Neuro-Oncology, Bangalore Oncology Group, and Indian Association of Hyperthermia Oncology.

Dr. Shruti Kate is a highly trained and experienced oncologist, specializing in the treatment of different types of cancer, including lung, breast, and gynecological cancers. She has done extensive research in the field, and was the sole recipient of a travel award from India in the 2018 World Conference on Lung Cancer.

Dr. Friedemann Schad is a specialist in Internal Medicine and Gastroenterology, and the head of the Oncology Center at the Gemeinschaftskrankenhaus Havelhöhe in Berlin, Germany. He is also a member of the Management of Gemeinschaftskrankenhaus Havelhöhe, the Research Institute Havelhöhe, Berlin, Netzwerk Onkologie, Tumorzentrum Berlin, and Tumorzentrum gemeinnütziger & denominational hospitals in Berlin eV

Oncosurgeon, specialist in the treatment of gastrointestinal tract organs